title: Peripheral blood granulocyte activity following contact sensitization of rats with dinitrochlorobenzene.
abstract: Contact hypersensitivity (CHS) reaction is a classic example of a cell-mediated reaction. As the afferent phase of the reaction includes inflammation, CHS is a suitable model for investigating non-specific immunity. Some aspects of granulocyte activity in the afferent phase of experimentally induced CHS to dinitrochlorobenzene (DNCB) in two genetically different rat strains, AO and DA were examined in this study. A shift in the ratio of granulocytes to lymphocytes in favour of granulocytes and an increase in granulocyte survival were noted in DA rats. Granulocytes from both strains demonstrated increased levels of NBT reduction and an increase in their adhesion to plastic. Decreased granulocyte adhesion in the presence of monoclonal antibodies to beta2 integrins (anti-CD11b/c and anti-CD18) points to the contribution of these molecules to granulocyte adhesiveness during the sensitization phase of CHS. Stimulation of adhesion in the presence of anti-CD11a antibody, points to a differential modulation of adhesion molecule activity during the afferent phase of CHS. Changes in functional activity of granulocytes demonstrated in this study might contribute to the development of CHS in rats.
authors.affiliation: Institute for Medical Research, Military Medical Academy, Crnotravska 17, Belgrade, Yugoslavia. vmaimi@eunet.yu
authors.forename: M
authors.initials: M
authors.lastname: Kataranovski
authors.forename: B
authors.initials: B
authors.lastname: Drasković-Pavlović
authors.forename: G
authors.initials: G
authors.lastname: Jovcić
authors.forename: G
authors.initials: G
authors.lastname: Milojević
authors.forename: V
authors.initials: V
authors.lastname: Todorović
authors.forename: M
authors.initials: M
authors.lastname: Colić
authors.forename: P
authors.initials: P
authors.lastname: Popović
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D018845:CD11 Antigens / Q000276:immunology; D018821:CD18 Antigens / Q000276:immunology; D002448:Cell Adhesion / Q000187:drug effects / Q000276:immunology; D002470:Cell Survival / Q000187:drug effects; D003877:Dermatitis, Contact / Q000097:blood* / Q000276:immunology; D004137:Dinitrochlorobenzene / Q000633:toxicity*; D004195:Disease Models, Animal; D004431:Ear, External / Q000187:drug effects / Q000473:pathology; D004487:Edema / Q000139:chemically induced / Q000473:pathology; D005562:Formazans / Q000378:metabolism; D006098:Granulocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D006241:Haptens / Q000276:immunology; D007958:Leukocyte Count; D009580:Nitroblue Tetrazolium / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012867:Skin / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D013045:Species Specificity; D013778:Tetrazolium Salts / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D018845:CD11 Antigens; D018821:CD18 Antigens; D004137:Dinitrochlorobenzene; D005562:Formazans; D006241:Haptens; D013778:Tetrazolium Salts; C079782:MTT formazan; D009580:Nitroblue Tetrazolium